Previzion Aksyon TG Therapeutics (TGTX)
Dernie pri$57.44Mizajou 25 Sep 2026 19:59 UTC
Chanjman-0.12%
Previzyon AI: TGTX
AI a pibliye yon pri objektif pou pwochen jou trading la, fen semenn nan ak fen mwa nan. Chanjman an mezire depi dènye pri a. Se estimasyon estatistik, se pa konsèy envestisman.
Pri lor dernie 6 mwa
Premium montre bann objektif pri AI pou 1 zour, 1 semenn ek 1 mwa pou sa aksyon la ek pou tou lot aksyon.
Debloke Premium🔒 Historik previzion
Historik previzion an — chak ansyen previzion bò kote klotir reyèl la — fè pati Premium.
Debloke PremiumSou Konpayi Sa a
TG Therapeutics, Inc. is a clinical-stage biopharmaceutical company specializing in the acquisition, development, and commercialization of innovative pharmaceutical products for the treatment of cancer and other underserved diseases. The company is developing two treatments for hematologic malignancies, specifically relapsed and refractory non-Hodgkin lymphoma.
